FAZIO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 406
EU - Europa 362
AS - Asia 114
AF - Africa 21
SA - Sud America 5
Totale 908
Nazione #
US - Stati Uniti d'America 400
IT - Italia 223
SG - Singapore 71
SE - Svezia 56
IN - India 29
AT - Austria 19
TG - Togo 18
BG - Bulgaria 14
GB - Regno Unito 8
BE - Belgio 7
DE - Germania 6
IE - Irlanda 6
FR - Francia 5
MY - Malesia 5
NL - Olanda 5
CA - Canada 4
CN - Cina 3
FI - Finlandia 3
AL - Albania 2
BR - Brasile 2
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
ID - Indonesia 2
MX - Messico 2
RO - Romania 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
IL - Israele 1
KH - Cambogia 1
NG - Nigeria 1
RU - Federazione Russa 1
TR - Turchia 1
UA - Ucraina 1
Totale 908
Città #
Rome 85
Chandler 66
Singapore 48
Fairfield 41
Ashburn 25
Princeton 20
Lomé 18
Vienna 18
Milan 16
Millbury 15
Sofia 14
Ann Arbor 12
Seattle 12
Wilmington 11
Andover 10
Boston 10
Cambridge 10
Florence 9
San Diego 9
Santa Clara 8
Woodbridge 8
Brussels 7
Houston 7
Dublin 6
Lawrence 5
San Paolo di Civitate 5
Tivoli 5
Artena 4
Brescia 4
New York 4
Norwalk 4
Paris 4
Toronto 4
Formia 3
Helsinki 3
London 3
Sleen 3
Stockholm 3
Beijing 2
Bengaluru 2
Bogotá 2
Bremen 2
Bühl 2
Camerino 2
Canary Wharf 2
Fiuggi 2
Guarulhos 2
Jakarta 2
Leverano 2
Los Angeles 2
Pavia 2
Prato 2
Ravenna 2
Tirana 2
Uzzano 2
Acquaviva delle Fonti 1
Al Ain City 1
Albano Laziale 1
Bagnacavallo 1
Barcelona 1
Bari 1
Bern 1
Bologna 1
Bolzano 1
Camden 1
Collegeville 1
Des Moines 1
Fasano 1
Federal 1
Fontanelle 1
Fremont 1
Frosinone 1
Genoa 1
Johor Bahru 1
Kosekoy 1
L'aquila 1
Las Vegas 1
Laurel 1
Mexico City 1
Muizenberg 1
Nettuno 1
Padova 1
Pathanamthitta 1
Phnom Penh 1
Portland 1
Pune 1
Redwood City 1
Samarate 1
San Mateo 1
Solna 1
Taranto 1
Tel Aviv 1
Trumbull 1
Velletri 1
Viano 1
Villarsiviriaux 1
Washington 1
Xuzhou 1
Totale 616
Nome #
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 128
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 59
New dead/H-Box helicase gene (Ddx41) mutation in an italian family with recurrent leukemia. 59
Response to interferon-free direct antivirals (DAAS) treatment in Hcv-related subcutaneous marginal zone B-cell lymphoma with lipoma-like presentation: report of two cases 58
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia 53
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: report from the Multiple Myeloma Gimema Lazio Group 41
Therapy regimens including Daratumumab for relapsed/refractory multiple myeloma patients: Report from the Multiple Myeloma GIMEMA Lazio Group 39
Relapsed/Refractory Multiple Myeloma Patients. A Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy 37
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going? 36
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome. 36
Real-World Patterns of Utilization and Outcome of Market Approved Lenalidomide-Based Triplet Combinations in First Relapsed Multiple Myeloma Patients: Evidence from a Propensity Score Matched Analysis 34
Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic malignancies in real-world practice. 34
The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab 32
Posterior reversible encephalopathy syndrome (PRES) as complication in a multiple myeloma 31
null 27
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells 24
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 24
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing 24
Monoclonal antibodies in multiple myeloma. 24
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment 24
5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance. 23
Single Molecule Real-Time Sequencing of the M Protein (SMaRT M-Seq): Toward Personalized Medicine Approaches in Monoclonal Gammopathies 20
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 17
4. High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate. 17
null 16
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript 15
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study 11
Autologous stem cell transplantation in multiple myeloma patients over 70 years: a GIMEMA Lazio Working Group experience in a retrospective case-control study 11
Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significance 7
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight 6
Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study 4
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity 4
null 3
Totale 978
Categoria #
all - tutte 3.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 4 2 4 3 1 5
2020/202157 2 6 3 0 0 1 3 22 7 5 6 2
2021/2022219 7 1 4 2 19 4 8 9 51 18 59 37
2022/2023352 66 47 39 24 52 46 8 12 30 1 15 12
2023/2024219 5 26 14 15 24 34 12 19 4 28 18 20
2024/2025112 30 51 31 0 0 0 0 0 0 0 0 0
Totale 978